“CGRP (calcitonin-gene-related peptide) is a specific biochemical which is being targeted through his new class of drugs. Clinical trials have proved that these drugs can be an effective measure in preventing migraine in a significant amount of the population of headache sufferers.
The American Headache Society chair of the scientific program and chief of the University of California, San Francisco Headache Center, Dr. Peter, Goadsby states that researchers have identified the important role CGRP plays in the development of migraine headaches, since 20 years.
It has been known since 20 years that the body requires CGRP in order to control the opening of blood vessels. Ward believes that CGRP plays a very vital role in pain signal transmission.
“The last step in the pathway we think to setting off headache is this substance called CGRP. This material is released by nerves, and when released it causes inflammation in the nervous system.” states Ward.
Ward is strong in his belief that this will be the first that migraine patients will get drugs for prevention.”
Great News For Migraine Sufferers – New Class Of Drug To Prevent Chronic Migraines